Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $149000.0.

  • Neurogene's Other Non Operating Income rose 419.58% to $149000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 9015.19%. This contributed to the annual value of $574000.0 for FY2024, which is 9649.04% down from last year.
  • Latest data reveals that Neurogene reported Other Non Operating Income of $149000.0 as of Q3 2025, which was up 419.58% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Other Non Operating Income ranged from a high of $16.4 million in Q4 2023 and a low of $143000.0 during Q1 2024
  • Moreover, its 3-year median value for Other Non Operating Income was $146000.0 (2024), whereas its average is $2.3 million.
  • Per our database at Business Quant, Neurogene's Other Non Operating Income crashed by 9911.95% in 2024 and then soared by 74166.67% in 2025.
  • Over the past 3 years, Neurogene's Other Non Operating Income (Quarter) stood at $16.4 million in 2023, then plummeted by 99.12% to $144000.0 in 2024, then increased by 3.47% to $149000.0 in 2025.
  • Its last three reported values are $149000.0 in Q3 2025, $1.2 million for Q2 2025, and $148000.0 during Q1 2025.